Børsen
Expectations of a market value of over 150 billion dollars for weight loss medication over the next decade do not faze the CEO of Novo Nordisk.
Expectations of a market value of over 150 billion dollars for weight loss medication over the next decade do not faze the CEO of Novo Nordisk.